GOSSAMER BIO
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bioโs strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
GOSSAMER BIO
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.gossamerbio.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
600 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
NextCure
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-07-17 | Adhaere Pharmaceuticals | Adhaere Pharmaceuticals acquired by Gossamer Bio | N/A |
Investors List
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Gossamer Bio
Boxer Capital
Boxer Capital investment in Post-IPO Equity - Gossamer Bio
Monashee Investment Management
Monashee Investment Management investment in Post-IPO Equity - Gossamer Bio
Invus
Invus investment in Post-IPO Equity - Gossamer Bio
Weiss Asset Management
Weiss Asset Management investment in Post-IPO Equity - Gossamer Bio
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Gossamer Bio
Madison Avenue Partners
Madison Avenue Partners investment in Post-IPO Equity - Gossamer Bio
Rock Springs Capital
Rock Springs Capital investment in Post-IPO Equity - Gossamer Bio
MidCap Financial
MidCap Financial investment in Post-IPO Debt - Gossamer Bio
Bay City Capital
Bay City Capital investment in Series B - Gossamer Bio
Key Employee Changes
Date | New article |
---|---|
2021-09-21 | Gossamer Bio Announces Appointment of Bryan Giraudo as Chief Operating Officer, in addition to Chief Financial Officer Role |
Official Site Inspections
http://www.gossamerbio.com Semrush global rank: 1.32 M Semrush visits lastest month: 22.23 K
- Host name: 104.26.4.137
- IP address: 104.26.4.137
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago